AMGN
Amgen Inc.
232.50
-
1.38
0.59%
8 x 233.28
8 x 233.37
bid
ask
12:23 PM
timesize
Bearish
11
Bullish
37
sentiment
231.46
day range
233.76
166.30
52 week range
235.80
Prev Close233.88
Open233.69
Low231.46
High233.76
Volume627.43K
Avg. Volume2.36M
Market Cap138.16B
Inst. Own81.92%
Beta1.10
Short Ratio3.87
Div & Yield5.80 / 2.49
EPS13.00
P/E17.88
1yr Target225.95
50day MA217.35
200day MA195.41
^DJI
Dow Jones Industrial Average
27595.54
12:23 PM
-
54.26
0.20%
^IXIC
NASDAQ Composite
8556.33
12:23 PM
-
10.34
0.12%
^GSPC
S&P 500
3109.44
12:23 PM
-
3.32
0.11%
AAPL
Apple Inc.
264.00
12:23 PM
9 x 264.11
8 x 264.19
+
2.26
0.86%
GOOG
Alphabet Inc.
1319.15
12:23 PM
10 x 1319.13
8 x 1319.57
-
1.39
0.11%
AMZN
Amazon.com, Inc.
1745.64
12:23 PM
8 x 1746.70
10 x 1746.99
-
15.05
0.85%
MSFT
Microsoft Corporation
149.88
12:23 PM
12 x 149.91
12 x 149.93
+
0.03
0.02%
FB
Facebook, Inc.
198.74
12:22 PM
10 x 198.87
10 x 198.88
+
0.03
0.02%
BABA
Alibaba Group Holding Limited
199.55
12:24 PM
8 x 199.16
9 x 199.10
+
5.81
3.00%
NFLX
Netflix, Inc.
301.00
12:23 PM
14 x 300.90
9 x 301.04
-
3.32
1.09%
TSLA
Tesla, Inc.
330.74
12:23 PM
8 x 330.31
9 x 330.45
-
2.29
0.69%
NVDA
NVIDIA Corporation
208.28
12:23 PM
18 x 208.38
8 x 208.44
-
1.14
0.54%
AMD
Advanced Micro Devices, Inc.
39.85
12:23 PM
12 x 39.93
40 x 39.94
+
0.16
0.40%
MU
Micron Technology, Inc.
46.41
12:23 PM
9 x 46.42
18 x 46.43
+
0.11
0.24%
SPY
SPDR S&P 500 ETF Trust
311.17
12:23 PM
10 x 311.39
11 x 311.39
-
0.29
0.09%
TQQQ
ProShares UltraPro QQQ
74.39
12:23 PM
18 x 74.57
10 x 74.56
-
0.25
0.33%
BRK-A
Berkshire Hathaway Inc.
328135.10
12:00 PM
12 x 328240.10
8 x 328541.30
+
634.10
0.19%
| Day Gain | ||
| Gain | ||
| Market Val | ||
| Costs | ||
| Cash | ||
| Portfolio | ||
| Realized | ||
| Dividend |
-
Heads-up Sell Cue; Amgen Inc. (AMGN) stock RSI shifts to 78.19
Viral News Place •0
Views -
Institutional Activity Declining in Shares of Amgen Inc. (NASDAQ:AMGN)
Beloit Bulletin •0
Views -
Amgen Inc. (AMGN) stock price is valued at $233.88
Market Seat •0
Views -
0
Views -
0
Views -
A Look At Some Cash Alternatives For Your Portfolios:: Amgen Inc.,(NASDAQ:AMGN)
Money Making News •0
Views -
Amgen Inc. [AMGN] Holding Strong: What’s pushing it?
The Dwinnex •0
Views -
0
Views -
0
Views -
FY2019 EPS Estimates for Amgen, Inc. Raised by Oppenheimer (NASDAQ:AMGN)
Mitchell Messenger •0
Views -
Stock In Active Zone:: Amgen Inc. (AMGN)
WEB NEWS OBSERVER •0
Views -
0
Views -
0
Views -
Putnam FL Investment Management Co. Sells 2,107 Shares of Amgen, Inc. (NASDAQ:AMGN)
Mitchell Messenger •0
Views -
Concentric Wealth Management LLC Purchases 52 Shares of Amgen, Inc. (NASDAQ:AMGN)
Mitchell Messenger •0
Views -
0
Views -
Amgen, Inc. (NASDAQ:AMGN) Shares Acquired by D.A. Davidson & CO.
Mitchell Messenger •0
Views -
0
Views -
0
Views -
Pacitti Group Inc. Acquires New Stake in Amgen, Inc. (NASDAQ:AMGN)
Slater Sentinel •0
Views -
EP Wealth Advisors LLC Makes New Investment in Amgen, Inc. (NASDAQ:AMGN)
Slater Sentinel •0
Views -
Amgen, Inc. (NASDAQ:AMGN) Shares Purchased by RDA Financial Network
Slater Sentinel •0
Views -
JT Stratford LLC Increases Stock Holdings in Amgen, Inc. (NASDAQ:AMGN)
Mitchell Messenger •0
Views -
Amgen, Inc. (NASDAQ:AMGN) Shares Purchased by Martin Capital Partners LLC
TechNewsObserver •0
Views -
0
Views -
AMG National Trust Bank Raises Position in Amgen, Inc. (NASDAQ:AMGN)
TechNewsObserver •0
Views -
Ancora Advisors LLC Buys 5,602 Shares of Amgen, Inc. (NASDAQ:AMGN)
Slater Sentinel •0
Views -
0
Views -
Welch Group LLC Raises Stake in Amgen, Inc. (NASDAQ:AMGN)
TechNewsObserver •0
Views -
Lowe Brockenbrough & Co. Inc. Has $5.88 Million Holdings in Amgen, Inc. (NASDAQ:AMGN)
Mitchell Messenger •0
Views -
0
Views
Profile
...
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, and neuroscience. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Aranesp to treat anemia; Xgeva for skeletal-related events prevention; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; and EPOGEN to treat a lower-than-normal number of red blood cells. It also markets other products in various markets, including Kyprolis, Nplate, Vectibix, Repatha, NEUPOGEN, Parsabiv, Blincyto, Aimovig, Imlygic, Corlanor, Kanjintitm, and Amgevitatm. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaborative agreements with Novartis; UCB; Bayer HealthCare Pharmaceuticals Inc.; Syapse; and DaVita Inc., as well as strategic research partnership with the University of Washington's Institute for Protein Design. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Earning
...
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2019-10-29 | 2019-09 | 3.51 | 3.66 | 0.15 | 4.27% |
| 2019-07-30 | 2019-06 | 3.58 | 3.97 | 0.39 | 10.89% |
| 2019-04-30 | 2019-03 | 3.45 | 3.56 | 0.11 | 3.19% |
| 2019-01-29 | 2018-12 | 3.26 | 3.42 | 0.16 | 4.91% |
| 2018-10-30 | 2018-09 | 3.42 | 3.69 | 0.27 | 7.89% |
| 2018-07-26 | 2018-06 | 3.52 | 3.83 | 0.31 | 8.81% |
Upgrade / Downgrade
...
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2019-11-11 | SunTrust Robinson Humphrey | Upgrade | Buy | |
| 2019-11-04 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| 2019-09-04 | Cantor Fitzgerald | Upgrade | Neutral | |
| 2019-08-28 | JP Morgan | Upgrade | Neutral | |
| 2019-08-26 | RBC Capital | Upgrade | Sector Perform | |
| 2019-08-26 | BMO Capital | Upgrade | Outperform |
Insider Holder
...
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2019-11-21 | GRAHAM JONATHAN P | General Counsel | 42.85K | Sale |
| 2019-05-02 | HERRINGER FRANK C | Director | 52.67K | Stock Award(Grant) |
| 2019-10-31 | HOLLEY CHARLES M JR | Director | 4.33K | Stock Award(Grant) |
| 2019-10-31 | JOHNSTON LORI A | Officer | 26.46K | Stock Award(Grant) |
| 2019-10-31 | KULLMAN ELLEN JAMISON | Director | 5.34K | Stock Award(Grant) |
| 2019-11-24 | MELINE DAVID W | Chief Financial Officer | 49.38K | Sale |
Institution Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2019-09-29 | Vanguard Group, Inc. (The) | 48.34M | 9.35B | 8.14% |
| 2019-09-29 | Blackrock Inc. | 46.02M | 8.90B | 7.74% |
| 2019-09-29 | Capital Research Global Investors | 33.59M | 6.50B | 5.65% |
| 2019-09-29 | State Street Corporation | 25.99M | 5.03B | 4.37% |
| 2019-09-29 | FMR, LLC | 24.40M | 4.72B | 4.11% |
| 2019-09-29 | Primecap Management Company | 18.20M | 3.52B | 3.06% |
Fund Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2019-06-29 | Vanguard Total Stock Market Index Fund | 17.02M | 3.14B | 2.86% |
| 2019-06-29 | Vanguard 500 Index Fund | 12.00M | 2.21B | 2.02% |
| 2019-06-29 | Vanguard/Primecap Fund | 10.52M | 1.94B | 1.77% |
| 2019-09-29 | Investment Company Of America | 7.63M | 1.48B | 1.28% |
| 2019-06-29 | Capital Income Builder, Inc. | 7.60M | 1.40B | 1.28% |
| 2019-08-30 | SPDR S&P 500 ETF Trust | 6.54M | 1.36B | 1.10% |
Dividend
...
| Dividend | Date |
|---|---|
| 1.45 | 2019-11-14 |
| 1.45 | 2019-08-14 |
| 1.45 | 2019-05-16 |
| 1.45 | 2019-02-14 |
| 1.32 | 2018-11-15 |
| 1.32 | 2018-08-16 |
Split
...
| Split | Date |
|---|---|
| 2 : 1 | 1999-11-22 |
